title: Treatment of inflammation with anti-ICAM-1.
authors.affiliation: Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT.
authors.forename: R
authors.initials: R
authors.lastname: Rothlein
authors.forename: E A
authors.initials: EA
authors.lastname: Mainolfi
authors.forename: T K
authors.initials: TK
authors.lastname: Kishimoto
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000628:therapy*; D018799:Intercellular Adhesion Molecule-1; D016028:Receptors, Leukocyte-Adhesion / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018821:CD18 Antigens; D015815:Cell Adhesion Molecules; D016028:Receptors, Leukocyte-Adhesion; D018799:Intercellular Adhesion Molecule-1